NO151282C - Analogifremgangsmaate til fremstilling av terapeutisk aktive para-substituerte 3-fenoksy-1-alkylamino-propanol-2-s som har beta-receptor blokkerende egenskaper - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive para-substituerte 3-fenoksy-1-alkylamino-propanol-2-s som har beta-receptor blokkerende egenskaper

Info

Publication number
NO151282C
NO151282C NO811799A NO811799A NO151282C NO 151282 C NO151282 C NO 151282C NO 811799 A NO811799 A NO 811799A NO 811799 A NO811799 A NO 811799A NO 151282 C NO151282 C NO 151282C
Authority
NO
Norway
Prior art keywords
preparation
alkylamino
phenoxy
propanol
substituted
Prior art date
Application number
NO811799A
Other languages
English (en)
Norwegian (no)
Other versions
NO811799L (no
NO151282B (no
Inventor
Enar Ingemar Carlsson
Bill Benjamin Rudol Gustafsson
Bo Torsten Lundgren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NO811799L publication Critical patent/NO811799L/no
Publication of NO151282B publication Critical patent/NO151282B/no
Publication of NO151282C publication Critical patent/NO151282C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO811799A 1980-06-02 1981-05-27 Analogifremgangsmaate til fremstilling av terapeutisk aktive para-substituerte 3-fenoksy-1-alkylamino-propanol-2-s som har beta-receptor blokkerende egenskaper NO151282C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8004087A SE8004087L (sv) 1980-06-02 1980-06-02 Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...

Publications (3)

Publication Number Publication Date
NO811799L NO811799L (no) 1981-12-03
NO151282B NO151282B (no) 1984-12-03
NO151282C true NO151282C (no) 1985-03-13

Family

ID=20341101

Family Applications (1)

Application Number Title Priority Date Filing Date
NO811799A NO151282C (no) 1980-06-02 1981-05-27 Analogifremgangsmaate til fremstilling av terapeutisk aktive para-substituerte 3-fenoksy-1-alkylamino-propanol-2-s som har beta-receptor blokkerende egenskaper

Country Status (25)

Country Link
EP (1) EP0041491B1 (enExample)
JP (1) JPS5724335A (enExample)
KR (1) KR850000869B1 (enExample)
AT (1) ATE11529T1 (enExample)
AU (1) AU548290B2 (enExample)
CS (1) CS241484B2 (enExample)
DD (1) DD159328A5 (enExample)
DE (1) DE3168595D1 (enExample)
DK (1) DK154208C (enExample)
ES (1) ES502656A0 (enExample)
FI (1) FI71725C (enExample)
GR (1) GR74571B (enExample)
HU (1) HU184860B (enExample)
IE (1) IE53801B1 (enExample)
LU (2) LU88317I2 (enExample)
MY (1) MY8600219A (enExample)
NL (1) NL930102I2 (enExample)
NO (1) NO151282C (enExample)
NZ (1) NZ197237A (enExample)
PH (1) PH16135A (enExample)
PL (1) PL135823B1 (enExample)
PT (1) PT73111B (enExample)
SE (1) SE8004087L (enExample)
SU (1) SU1156592A3 (enExample)
ZA (1) ZA812981B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4455317A (en) * 1981-06-23 1984-06-19 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4578403A (en) * 1981-06-23 1986-03-25 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4559359A (en) * 1981-06-23 1985-12-17 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
US4829086A (en) * 1984-03-14 1989-05-09 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
EP0174956B1 (en) * 1984-03-14 1990-08-16 BODOR, Nicholas S. SOFT $g(b)-ADRENERGIC BLOCKING AGENTS
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
AU575153B2 (en) * 1984-04-09 1988-07-21 Du Pont Merck Pharmaceutical Company, The Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders
AU607437B2 (en) * 1986-09-02 1991-03-07 Du Pont Pharmaceuticals Company Resolution of dl-methyl 3-(4-(2-hydroxy-3-isopropylamino) propoxy)phenylpropionate((dl-esmolol))
US5274002A (en) * 1987-04-14 1993-12-28 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
CA2015730C (en) * 1989-05-12 1997-10-07 Sadahiko Iguchi Esters of phenylalkanoic acid
US5232948A (en) * 1990-09-10 1993-08-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted monocyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
US20160333948A1 (en) * 2014-01-29 2016-11-17 Sumitomo Bakelite Co., Ltd. Brake pad and caliper device
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB673413A (en) * 1950-03-22 1952-06-04 Rhone Poulenc Sa New local anaesthetics which are substituted benzoic esters and processes for making the same
SE358382B (enExample) * 1967-12-18 1973-07-30 Boehringer Sohn Ingelheim
GB1285038A (en) 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
SE354851B (enExample) * 1970-02-18 1973-03-26 Haessle Ab
FR2132570B1 (enExample) 1971-04-09 1974-08-02 Lipha
PT66890B (fr) * 1976-08-21 1979-01-25 Hexachimie Procede pour la preparation des aryloxy-1 amino-3 propanol-2

Also Published As

Publication number Publication date
PL135823B1 (en) 1985-12-31
ATE11529T1 (de) 1985-02-15
NL930102I2 (nl) 1994-12-01
PT73111A (en) 1981-07-01
ES8300679A1 (es) 1982-11-01
DK239581A (da) 1981-12-03
NO811799L (no) 1981-12-03
ES502656A0 (es) 1982-11-01
CS404781A2 (en) 1985-06-13
JPS5724335A (en) 1982-02-08
NL930102I1 (nl) 1993-10-01
DK154208B (da) 1988-10-24
ZA812981B (en) 1982-05-26
SE8004087L (sv) 1981-12-03
MY8600219A (en) 1986-12-31
FI811671L (fi) 1981-12-03
SU1156592A3 (ru) 1985-05-15
EP0041491B1 (en) 1985-01-30
DK154208C (da) 1989-03-20
KR830006177A (ko) 1983-09-20
PL231450A1 (en) 1983-03-28
AU548290B2 (en) 1985-12-05
GR74571B (enExample) 1984-06-29
PH16135A (en) 1983-07-08
KR850000869B1 (ko) 1985-06-22
DE3168595D1 (en) 1985-03-14
PT73111B (en) 1983-05-11
NO151282B (no) 1984-12-03
JPS639501B2 (enExample) 1988-02-29
LU88348I2 (fr) 1994-09-09
CS241484B2 (en) 1986-03-13
EP0041491A1 (en) 1981-12-09
DD159328A5 (de) 1983-03-02
FI71725C (fi) 1987-02-09
IE811217L (en) 1981-12-02
FI71725B (fi) 1986-10-31
NZ197237A (en) 1985-01-31
AU7116681A (en) 1982-12-02
LU88317I2 (fr) 1994-05-04
HU184860B (en) 1984-10-29
IE53801B1 (en) 1989-03-01

Similar Documents

Publication Publication Date Title
AU548290B2 (en) Para-substituted 3-phenoxy-1-alkylamino-propan-2-01 beta receptor blocking compounds
PT97689A (pt) Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida
OA04766A (fr) Dérivés de cyclohexane, leur procédé de préparation et compositions herbicides utilisant ces composés.
IL72120A (en) 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them
FR2359125A1 (fr) Nouveaux derives de prostaglandine, leur procede de preparation et medicament les contenant
AU549890B2 (en) Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
FR2367055A1 (fr) Nouveaux derives d'alcanolamines, leur procede de preparation et composition pharmaceutique les contenant
DK166384C (da) Analogifremgangsmaade til fremstilling af (-)-15-deoxyspergualing og farmaceutisk acceptable syreadditionsssalte heraf samt mellemprodukt
FR2361358A1 (fr) Nouveaux derives de la phenyluree utilisables pour la lutte contre la vegetation indesirable, et leur preparation

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN MAY 2001